ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

Barnett Kramer Retires From NIH

January 7, 2011

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

President Accepts Rauscher Resignation

October 1, 1976

N.J. Congressman Seeks Increase In Prevention Effort

March 10, 1978

Cancer Control, Smoking Programs Reorganized

December 7, 1990